Amaryl®М SR: a New Release Form, New Possibilities for The Patients
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 5, Issue 69
Abstract
The review deals with a new form of oral antidiabetic drugs with a fixed dose — the combination of sustained-release metformin and glimepiride. Amaryl®M SR (2/500 mg) — a new dosage form, which provides a rapid release of glimepiride, and then the slow release of metformin from multipolymer hydrophilic matrix independently of pH. Based on the research of therapeutic efficacy and bioavailability, it is shown that this form is characterized by an optimal pharmacokinetics of metformin and glimepiride, does not increase the incidence of hypoglycemia, may be administered once a day, and is associated with less severe gastrointestinal side effects, as well as has more pronounced compliance. Application of Amaryl®M SR creates new possibilities for patients with type 2 diabetes mellitus in terms of optimizing glycemic control and quality of life.
Authors and Affiliations
V. V. Роltorak, M. Yu. Gorshunska, N. S. Krasova
Keywords
Related Articles
- EP ID EP219667
- DOI -
- Views 43
- Downloads 0
The Use of Sugar Substitutes and Sweeteners in Diet Therapy of Diabetes and Obesity
The article provides a description of the main sugar substitutes and sweeteners that do not have negative impact on glycaemic parameters and can be used by patients with with diabetes mellitus and obesity without the fea...
The Possibilities of Drug Prevention of Diabetes Mellitus Type 2
Over the past few years there have been several randomized controlled trials that examine the effect of lifestyle modification and pharmacological interventions on the likelihood of developing diabetes mellitus (DM) type...
The Many Faces of Glimepiride: on the Question of Interchangeability of Oral Hypoglycemic Agents
The article presents a literature review on the use of glimepiride while treating patients with diabetes mellitus. Characteristics of generic drugs of glimepiride are provided.
Influence of Hyperhomocysteinemia Correction on Functional Liver Tests and Lipid Profile in Patients with onalcoholic Fatty Liver Disease in Combination with Type 2 Diabetes Mellitus
Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM) are the components of metabolic syndrome, the incidence of which is increasing in the world every year. The article presents the results of treat...
Clinical Approaches to the Treatment of Diabetic Neuropathy
The article is devoted to the treatment of diabetic neuropathy. The described scheme of application of preparations of alpha-lipoic (thioctic) acid. Recently in Europe and the United States conducted a series of clinical...